Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Recombinant adiponectin antigen, antibody and adiponectin nano latex-enhanced turbidimetric immunoassay kit

A technology of adiponectin and recombinant lipids, which is applied in the direction of anti-hormone immunoglobulin, anti-animal/human immunoglobulin, hormone peptide, etc., can solve the problem of abnormal value of adiponectin that cannot be clearly defined. Significance, unexplained measured adiponectin normal level and reference range, limiting adiponectin clinical promotion and application, etc., to achieve good prediction effect, high accuracy, and simple steps

Active Publication Date: 2018-09-25
广东英诺生物科技有限公司
View PDF7 Cites 5 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the current international production of recombinant adiponectin by mammalian systems is low in yield and high in cost (yield is about 2mg / L, patent: US 7,365,170 B2), which limits the promotion and application of this recombinant antigen in the detection of adiponectin
[0009] More importantly, most of the current research on adiponectin, such as the above-mentioned patents, did not conduct detailed clinical verification of the reagents produced, did not describe the normal level and reference range of adiponectin measured, and failed to clarify the adiponectin level. The range of abnormal values ​​and the significance of measured abnormal values, and the predictive function of adiponectin for type 2 diabetes and pre-diabetes have not been clinically verified, which further limits the clinical promotion and application of adiponectin detection

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Recombinant adiponectin antigen, antibody and adiponectin nano latex-enhanced turbidimetric immunoassay kit
  • Recombinant adiponectin antigen, antibody and adiponectin nano latex-enhanced turbidimetric immunoassay kit
  • Recombinant adiponectin antigen, antibody and adiponectin nano latex-enhanced turbidimetric immunoassay kit

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0044] Example 1 Expression of adiponectin antigen

[0045] 1) Recombinant adiponectin antigen expressed by mammalian cells in the prior art

[0046] Reference reports (US 7,365,170 B2; Xu A, et al.Testosterone selectively reduces the high molecular weight form of adiponectin by inhibiting its secretion from adipocytes.J Biol Chem.2005May 6;280(18):18073-80) Antigen expression method. First, using the upstream primer: 5′-GCCCG CGGAT CCATG CTGTT GCTGG GAGCT GTTC-3′ and the downstream primer: 5′-GGCCG CGAAT TCTCA CTTGT CATCG TCGTC CTTGT AGTCG TTGGT GTCATGGTAG AGAAG-3′ from the human adipocyte DNA library (Clontech Corporation, USA) to amplify the gene encoding the adiponectin protein. After treatment with restriction endonuclease BamHI / EcoRI, insert the human adiponectin gene into the expression vector pRSET A, which is stronger than the vector pcDNA3.1 promoter reported in the literature, and insert and express it at the carboxyl end of the adiponectin gene The DNA sequence ...

Embodiment 2

[0049] Example 2 Preparation of Adiponectin Antibody

[0050]Take the natural adiponectin antigen disclosed in the prior art (CN 103777023 B, purchased from Bio-Rad Company, referred to as antigen A, and the antibody produced by it is referred to as antibody A), the recombinant adiponectin antigen of the prior art (US 7,365,170 B2 , referred to as antigen B, and the antibody produced by it is referred to as antibody B), and each 300 μg of adiponectin antigen expressed by mammalian cells of the present invention was emulsified with an equal amount of Freund's complete adjuvant (purchased from Sigma), and multiple points were placed subcutaneously on the back. Inject New Zealand white rabbits of 2.2-2.5kg in a specific pathogen-free (SPF) animal room, and then emulsify the antigen with Freund's incomplete adjuvant (Sigma) every two weeks, and repeat the same method for boosting Immunized 3 times, immunized 4 times in total. Then, 100ml of blood was drawn from the veins of rabbi...

Embodiment 3

[0051] Example 3 Preparation of latex particles coated with anti-human adiponectin polyclonal antibody

[0052] The three kinds of antibodies obtained in Example 2, namely Antibody A, Antibody B and the antibody of the present invention, were coupled to the surface of latex particles by chemical bonding. The latex particles were purchased from Bangslab. group. And using the antibody prepared from the adiponectin antigen expressed by the mammalian cells of the present invention, it is used to optimize the antibody concentration for preparing latex particles.

[0053] Specific steps are as follows:

[0054] 1) 100 mg of carboxyl-containing latex particles were dissolved in 5 ml of MOPS buffer (50 mM, pH 6.4) to obtain a latex particle solution.

[0055] 2) The adiponectin-specific antibody to be cross-linked was dissolved in 5ml of MOPS buffer (50mM, pH 6.4) to a concentration of 1-5mg / ml to obtain an antibody solution; the optimized antibody had a concentration of 3mg / ml.

...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Wavelengthaaaaaaaaaa
Login to View More

Abstract

The invention discloses a recombinant adiponectin antigen. A preparation method of the recombinant adiponectin antigen includes the steps of a, culturing a high-expression recombinant human full-length adiponectin protein cell strain in a high-glucose DMEM culture medium under oxygen input quantity of 0.25-0.75L / minute, carbon dioxide quantity of 5-10%, bovine serum quantity of 5-10% and rotationspeed of 100-200rpm to allow the cell number of the cell strain to reach 1-3*10<7>; b, replacing the culture medium with a serum-free culture medium, adding 0.5% of vitamin C, and allowing the cell strain to keep the cell number of 1-3*10<7> and continuously express adiponectin for 4-10 days. The invention further discloses an adiponectin antibody, adiponectin antibody nano latex particles and a kit containing the antigen and the antibody nano latex particles. The kit using the nano latex-enhanced turbidimetric immunoassay to detect adiponectin is high in accuracy, real and reliable in data and good in predicting effect on type 2 diabetes and pre-diabetes.

Description

technical field [0001] The invention relates to the field of biotechnology, in particular to a recombinant adiponectin antigen, antibody and adiponectin nano-latex enhanced immune turbidimetry kit and application thereof. Background technique [0002] With the progress of society, changes in the age structure of the population and changes in living habits, the incidence of diabetes has increased rapidly and has become a global epidemic (American Diabetes Association, Diabetes care36Suppl 1:S67-74(2013)). According to the International Diabetes Federation, there are currently more than 380 million diabetic patients worldwide, and 46% of them are not discovered until serious diabetic complications occur. According to statistics, the global annual expenditure on diabetes health care exceeds 548 billion US dollars (International Diabetes Federation, IDF Diabetes Atlas, 6th edition / 2013 update (2013)). According to recent epidemiological surveys, the prevalence of diabetes in my...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07K14/575C07K16/26G01N33/74
CPCC07K14/5759C07K16/26G01N33/74G01N2800/042
Inventor 徐爱民周鹏程钟铃赖华
Owner 广东英诺生物科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products